PSY83 - IMPACT OF DOSE ESCALATION ON AVERAGE COST AND COST-EFFECTIVENESS OF ANTI-TNF AND USTEKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN SWEDEN
Abstract
Authors
F. Ziegler E. Apol A. Egeberg
F. Ziegler E. Apol A. Egeberg
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now